CompletedPhase 2NCT03848481

CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS)

Studying Prader-Willi syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Montefiore Medical Center
Principal Investigator
Eric Hollander, MD
Montefiore Medical Center/Albert Einstein College of Medicine
Intervention
CBDV Compound(drug)
Enrollment
14 enrolled
Eligibility
5-30 years · All sexes
Timeline
2020 – 2024

Study locations (1)

Collaborators

Foundation for Prader-Willi Research · GW Pharmaceuticals Ltd

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03848481 on ClinicalTrials.gov

Other trials for Prader-Willi syndrome

Additional recruiting or active studies for the same condition.

See all trials for Prader-Willi syndrome →

← Back to all trials